Evaluation of suspected local recurrence in head and neck cancer: A comparison between PET and PET/CT for biopsy proven lesions

European Journal of Radiology

Volumn 62, Issue 2, 2007, Pages 199-204

  Halpern, Benjamin S ^a,b   Yeom, Kristen ^a   Fueger, Barbara J ^a   Lufkin, Robert B ^a   Czernin, Johannes ^a   Allen Auerbach, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Head and neck cancer; PET CT; Re staging

Indexed keywords

BIOPSY; ENDOSCOPY; HISTOLOGY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; ULTRASONOGRAPHY;

CANCER DETECTION; NECK CANCERS; RESTAGING; TUMOR RESECTION;

TUMORS;

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; EVALUATION; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LYMPH NODE DISSECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY;

ADULT; AGED; BIOPSY; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RESEARCH DESIGN; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34147163655     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2006.11.037     Document Type: Article

References (26)

1. Gambhir S.S., Czernin J., Schwimmer J., Silverman D.H., Coleman R.E., and Phelps M.E. A tabulated summary of the FDG PET literature. J Nucl Med 42 5 Suppl. (2001) 1S-93S
2. Adams S., Baum R.P., Stuckensen T., Bitter K., and Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25 9 (1998) 1255-1260
3. Hubner K.F., Thie J.A., Smith G.T., Chan A.C., Fernandez P.S., and McCoy J.M. Clinical utility of FDG-PET in detecting head and neck tumors. A comparison of diagnostic methods and modalities. Clin Positron Imaging 3 1 (2000) 7-16
4. Lowe V.J., Kim H., Boyd J.H., Eisenbeis J.F., Dunphy F.R., and Fletcher J.W. Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-d-glucose PET imaging. Radiology 212 3 (1999) 799-802
5. Antoch G., Vogt F.M., Freudenberg L.S., Nazaradeh F., Goehde S.C., Barkhausen J., et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290 24 (2003) 3199-3206
6. Branstetter B.F.t., Blodgett T.M., Zimmer L.A., Snyderman C.H., Johnson J.T., Raman S., et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone?. Radiology 235 2 (2005) 580-586
7. Cohade C., Osman M., Leal J., and Wahl R.L. Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 44 11 (2003) 1797-1803
8. Lardinois D., Weder W., Hany T.F., Kamel E.M., Korom S., Seifert B., et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348 25 (2003) 2500-2507
9. Schoder H., Yeung H.W., Gonen M., Kraus D., and Larson S.M. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 231 1 (2004) 65-72
10. Beyer T., Townsend D.W., Brun T., Kinahan P.E., Charron M., Roddy R., et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 41 8 (2000) 1369-1379
11. Goerres G.W., Von Schulthess G.K., and Hany T.F. Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment. AJR Am J Roentgenol 179 5 (2002) 1337-1343
12. Metz C.E. ROC methodology in radiologic imaging. Invest Radiol 21 9 (1986) 720-733
13. Farber L.A., Benard F., Machtay M., Smith R.J., Weber R.S., Weinstein G.S., et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-d-glucose positron emission tomography. Laryngoscope 109 6 (1999) 970-975
14. McGuirt W.F., Greven K., Williams III D., Keyes Jr. J.W., Watson N., Cappellari J.O., et al. PET scanning in head and neck oncology: a review. Head Neck 20 3 (1998) 208-215
15. Stokkel M.P., Terhaard C.H., Hordijk G.J., and van Rijk P.P. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med 26 7 (1999) 767-773
16. Laubenbacher C., Saumweber D., Wagner-Manslau C., Kau R.J., Herz M., Avril N., et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 36 10 (1995) 1747-1757
17. Kostakoglu L., Wong J.C., Barrington S.F., Cronin B.F., Dynes A.M., and Maisey M.N. Speech-related visualization of laryngeal muscles with fluorine-18-FDG. J Nucl Med 37 11 (1996) 1771-1773
18. Shreve P.D., Anzai Y., and Wahl R.L. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 19 1 (1999) 61-77 quiz 150-1
19. Cook G.J., Fogelman I., and Maisey M.N. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med 26 4 (1996) 308-314
20. Heller M.T., Meltzer C.C., Fukui M.B., Rosen C.A., Chander S., Martinelli M.A., et al. Superphysiologic FDG uptake in the non-paralyzed vocal cord. Resolution of a false-positive PET result with combined PET-CT imaging. Clin Positron Imaging 3 5 (2000) 207-211
21. Fogarty G.B., Peters L.J., Stewart J., Scott C., Rischin D., and Hicks R.J. The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor. Head Neck 25 2 (2003) 138-145
22. Lapela M., Grenman R., Kurki T., Joensuu H., Leskinen S., Lindholm P., et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-d-glucose. Radiology 197 1 (1995) 205-211
23. Lonneux M., Lawson G., Ide C., Bausart R., Remacle M., and Pauwels S. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope 110 9 (2000) 1493-1497
24. Nahas Z., Goldenberg D., Fakhry C., Ewertz M., Zeiger M., Ladenson P.W., et al. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope 115 2 (2005) 237-243
25. Slomka P.J. Software approach to merging molecular with anatomic information. J Nucl Med 45 Suppl. (1) (2004) 36S-45S
26. Yoon D.Y., Chang K.H., Han M.H., Kim H.D., Kim S.H., Kim T.K., et al. Re-evaluation of optimal dose of contrast medium for vascular enhancement in CT of the head and neck. Neuroradiology 39 1 (1997) 30-34